Artiva Biotherapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Artiva Biotherapeutics stock have an average target of 20, with a low estimate of 18 and a high estimate of 23. The average target predicts an increase of 532.91% from the current stock price of 3.16.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$18	$20	$20	$23
Change	+469.62%	+532.91%	+532.91%	+627.85%

Analyst Ratings

The average analyst rating for Artiva Biotherapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	3	3	4	4	4	4
Buy	2	2	2	2	2	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	6	6	6	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $20	Strong Buy	Reiterates	$20	+532.91%	Mar 26, 2025
Martin Fan Wedbush	Wedbush	Buy Reiterates $18	Buy	Reiterates	$18	+469.62%	Mar 25, 2025
Josh Schimmer Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $23 → $20	Buy	Maintains	$23 → $20	+532.91%	Mar 25, 2025
Gil Blum Needham	Needham	Strong Buy Reiterates $23	Strong Buy	Reiterates	$23	+627.85%	Mar 25, 2025
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $20	Strong Buy	Initiates	$20	+532.91%	Dec 30, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 251.00K

Revenue Next Year

n/a

EPS This Year

-2.98

from -5.81

EPS Next Year

-2.48

from -2.98

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	2.00M	4.93M	33.49M	251.00K	-	-	-
Revenue Growth	-	-	146.30%	579.21%	-99.25%	-	-	-
EPS	-28.49	-104.73	-76.67	-35.78	-5.81	-2.98	-2.48	-2.58
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026	2027
High	-2.54	-0.82	-0.97
Avg	-2.98	-2.48	-2.58
Low	-3.33	-3.18	-3.72

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.